Gomila, Aina http://orcid.org/0000-0001-6979-9269
Shaw, Evelyn
Carratalà, Jordi
Leibovici, Leonard
Tebé, Cristian
Wiegand, Irith
Vallejo-Torres, Laura
Vigo, Joan M.
Morris, Stephen
Stoddart, Margaret
Grier, Sally
Vank, Christiane
Cuperus, Nienke
Van den Heuvel, Leonard
Eliakim-Raz, Noa
Vuong, Cuong
MacGowan, Alasdair
Addy, Ibironke
Pujol, Miquel
,
Funding for this research was provided by:
Innovative Medicines Initiative Joint Undertaking (115523 | 115620 | 115737)
Article History
Received: 24 July 2018
Accepted: 29 August 2018
First Online: 14 September 2018
Ethics approval and consent to participate
: This study was approved by the local research ethics committee of each site. The processing of patients’ personal data was anonymised and complied with local data protection legislations and with the European Union Data Protection Directive (95/46/EC). As no individual data is published as well as no intervention was performed to patients, patient consent was waived by the Ethics Committee.
: No applicable.
: Authors IA, CV, IW, and CV belong to EFPIA (European Federation of Pharmaceutical Industries and Association) member companies in the IMI JU and costs related to their part in the research were carried by the respective company as in kind contribution under the IMI JU scheme. Other authors declare no potential conflicts.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.